FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE

Details for Australian Patent Application No. 2003278812 (hide)

Owner EXELIS, INC.

Inventors Francis-Lang, Helen; Lickteig, Kim; Kidd, Thomas; Roche, Siobhan; Friedman, Lori

Agent Davies Collison Cave

Pub. Number AU-A-2003278812

PCT Number PCT/US03/28903

PCT Pub. Number WO2004/024882

Priority 60/411,010 16.09.02 US

Filing date 15 September 2003

Wipo publication date 30 April 2004

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/411,010 16.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003278812

19 May 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Exelis, Inc. to Exelixis, Inc.

5 July 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278813-PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE

2003278811-LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE